Table of contents
November 2006 Volume 3 No 11
Top of page
Editorial
Top of page
Viewpoint
Top of page
Research Highlights
Annual PSA screening might reduce mortality from recurrent prostate cancer
570Erectile dysfunction—an early marker of diabetes mellitus?
570SUI at first pregnancy increases the risk of long-term symptoms
570Peripheral biopsies maximize cancer detection in 12-core prostate biopsy protocols
571How effective are endoscopic gel injections in treating pediatric vesicoureteral reflux?
571Preoperative CT scans might overestimate the size of renal tumors
572Antimuscarinic agents might impair memory in older people
572Toremifene could prevent prostate cancer in high-risk patients
572Baseline FSH levels could identify men with impaired testicular functioning
573Finasteride suppresses prostate angiogenesis in vivo
573New device that objectively measures ejaculatory latency time
574New complication associated with collagen injections for incontinence
574Sildenafil is safe and effective in recipients of renal transplants
574Top of page
Practice Points
Is there a role for preoperative renal core biopsy?
576PSA bounce versus biochemical failure following prostate brachytherapy
578Erosions of the artificial urinary sphincter: risk factors, outcomes and management
580Repeat transurethral resection lowers recurrence rates in T1 bladder tumors, even after intravesical mitomycin C
582Spontaneous bladder perforations following augmentation cystoplasty in children
584An argument to screen for distress in men diagnosed with early-stage prostate cancer
586Top of page
Reviews
Mechanisms of Disease: the role of heat-shock protein 90 in genitourinary malignancy
590doi:10.1038/ncpuro0604 | Full Text | PDF (392K)
Technology Insight: radioguided sentinel lymph node dissection in the staging of prostate cancer
602doi:10.1038/ncpuro0625 | Full Text | PDF (328K)
Technology Insight: telementoring and telesurgery in urology
611doi:10.1038/ncpuro0626 | Full Text | PDF (281K)
Top of page
Case Study
Top of page
Erratum
A combination of intravesical BCG and electromotive mitomycin for high-risk superficial bladder cancer
623doi:10.1038/ncpuro0646 | Full Text | PDF (286K)


